Safety, efficacy, and affordability of ABVD for Hodgkin lymphoma in Malawi: a prospective cohort studyResearch in context

Safety, efficacy, and affordability of ABVD for Hodgkin lymphoma in Malawi: a prospective cohort studyResearch in context

Summary: Background: ABVD (doxorubicin, bleomycin, vinblastine, and dexamethasone) is a proven, curative regimen for Hodgkin lymphoma (HL). Prospective data describing HL treatment in sub-Saharan Africa are limited. We aimed to fill this knowledge gap, using data from Malawi. Methods: We report a p...

Full description

Bibliographic Details
Main Authors: Marriam Mponda, Evaristar Kudowa, Dalton M. Craven, Luke C. Eastburg, Maria Chikasema, Edwards Kasonkanji, Tamiwe Tomoka, Sophie Maharry Roush, Lusayo Simwinga, Noel Mumba, Satish Gopal, Yuri Fedoriw, Matthew S. Painschab
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:EClinicalMedicine
Subjects:
Hodgkin lymphoma
HIV
ABVD
Sub-Saharan Africa
Cost
Microcosting
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537024000592

Internet

http://www.sciencedirect.com/science/article/pii/S2589537024000592

Similar Items